grey market retatrutide Stay tuned for part 2!! , and the market- what do I have right? And what do I have wrong? , -would love to hear all of your thoughts below! ⬇️ , Please be kind to each other, What to Know About the

A major element of our concern is that unbalanced and inappropriate reductions in caloric (energy) intake could be induced by GLP-1RA in children and adolescents

For patients requiring additional control, a 2 mg weekly dose is also licensed in the UK after at least four weeks at the 1 mg dose

There have now been many studies and analyses that suggest that the use of GLP-1 drugs goes beyond just weight loss and diabetes, with potential benefits ranging from helping mental illness and substance abuse to kidney disease, heart disease and even osteoarthritis, he added

In a 2024 joint court filing, the two companies said that the safety profile of GLP-1 RAs has been well-established in hundreds of clinical trials, large-scale observational studies, and nearly two decades of real-world use